January 10, 2008 NASD OTC-BB: MRDAF (MARKET WIRE)

Meridian Co., Ltd.: Lapex 2000 LipoLaser Global Distribution Now Includes the Persian Gulf

Meridian Co., Ltd. ("Meridian") (OTC BB:MRDAF.OB - News), announced today that the Company completed a private equity financing in Korea on December 19, 2007, pursuant to which the Company sold 1,976,666 restricted shares of common stock, at a price of 900 Won (approximately US$0.964) per share, providing proceeds of approximately US$1,905,506.

Participants in the private placement were mostly existing Korean shareholders of the Company. Proceeds from the financing will be used to reduce the debt load of the Company and to fund the Company's marketing program in North America and Europe.

No investment bank or financial advisor was used in the transaction. The Company's management team arranged and closed the transaction.

The private placement shares represent approximately 6% of the 33,027,490 shares of the common stock of the Company issued and outstanding on the date of the private placement. The number of shares of the common stock par value 100 Won of the Company issued and outstanding now totals 35,004,156.

More about: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds 5 registered and pending patents, 2 design rights and 7 trademarks, and has received FDA approval and Health Canada approval as well as other international regulatory approvals, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in Korea, USA, Canada, China, Japan and Europe, and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca